- COMPASS Pathways ( NASDAQ: CMPS ) appointed Kabir Nath as CEO, effective Aug.1, 2022; current CEO and chairman George Goldsmith will serve as Executive Chairman from Aug.1 to Dec.31, 2022. for facilitating transition and then remain as chairman.
- Most recently, Kabir Nath served as Senior Managing Director of global pharmaceuticals at Otsuka Pharmaceutical and prior to that as President and CEO of Otsuka’s North America Pharmaceutical Business.
- Mr. Nath will build on the company's success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental health care.
- Shares trading 3.6% higher premarket.
For further details see:
COMPASS Pathways names new CEO